This company has shut down. Beckley Psytech is no longer operating — its last tracked round was a Undisclosed in 2024.
Explore the Startup GraveyardBeckley Psytech is a biotechnology company developing psychedelic-based medicines for mental health conditions.
Beckley Psytech has raised $40.0M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2024.
Beckley Psytech's investors include Adage Capital Management, FJ Labs, Prime Movers Lab, Bossa Invest, AtaiBeckley.
Beckley Psytech is headquartered in Beckley, United Kingdom.
Beckley Psytech is a biotechnology company developing psychedelic-based medicines for mental health conditions.
Beckley Psytech is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beckley Psytech — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/beckley-psytech. Accessed September 29, 2026.
VCBacked. (2024). Beckley Psytech — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/beckley-psytech
{{cite web |title=Beckley Psytech — Funding & Investors |url=https://www.vcbacked.co/company/beckley-psytech |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated